MRK vs PFE
By Alex · Tickerpine
Merck & Co., Inc. vs Pfizer Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | PFE |
|---|---|---|
| Price | $147.76 | $28.89 |
| Market cap | $364.26B | $164.67B |
| P/E ratio | 149.3 | 41.3 |
| ROE | 5.06% | 4.47% |
| Profit margin | 3.64% | 6.34% |
| Revenue growth | 4.70% | -0.40% |
| Dividend yield | 2.30% | 5.95% |
| Beta | 0.12 | 0.30 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs PFE in plain English
- MRK is the bigger company — about 2.2× the market cap of PFE.
- PFE is cheaper on earnings (P/E 41.3 vs 149.3).
- MRK earns a higher return on equity (5% vs 4%).
- MRK is growing revenue faster (5% vs -0%).
- PFE has the higher dividend yield (5.95% vs 2.30%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
PFE return calculator
See what $1,000 in Pfizer Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.